Zymeworks Catalyst Calendar
Proactively evaluate Zymeworks Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Zymeworks Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 01 Dec 2021 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 15 Oct 2021 | Phase II Trial Initiation | University of Texas MD Anderson Cancer Center; Zymeworks Inc | ZYME | zanidatamab | Oncology | Breast Cancer; Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer) | Clinical Trial Registry |
| 16 Sep 2021 | Phase II Trial Results | Sarah Cannon Research Institute LLC; Zymeworks Inc | ZYME | zanidatamab | Oncology | Adenocarcinoma Of The Gastroesophageal Junction; Bile Duct Cancer (Cholangiocarcinoma) ; Colorectal Cancer; Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Gastric Cancer; Gastroesophageal (GE) Junction Carcinomas; Gastrointestinal Tumor | Company Press Release |
| 01 Dec 2020 | Phase II Trial Initiation | Pfizer Inc; PPD Inc; Sarah Cannon Research Institute LLC; Zymeworks Inc | PFE; ZYME | zanidatamab | Oncology | Breast Cancer; Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer); Metastatic Breast Cancer | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward